ADAPTIVE Trademark

Trademark Overview


On Monday, January 11, 2021, a trademark application was filed for ADAPTIVE with the United States Patent and Trademark Office. The USPTO has given the ADAPTIVE trademark a serial number of 90459478. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by Adaptive Biotechnologies Corp.. The ADAPTIVE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person

Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and...
adaptive

General Information


Serial Number90459478
Word MarkADAPTIVE
Filing DateMonday, January 11, 2021
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6919051
Registration DateTuesday, December 6, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements


Description of MarkThe mark consists of the word "ADAPTIVE" in stylized form with the letter "A" being capitalized.
Goods and ServicesProviding medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person
Goods and ServicesProviding medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 11, 2021
Primary Code042
First Use Anywhere DateFriday, January 1, 2021
First Use In Commerce DateFriday, January 1, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 11, 2021
Primary Code044
First Use Anywhere DateFriday, January 1, 2021
First Use In Commerce DateFriday, January 1, 2021

Trademark Owner History


Party NameAdaptive Biotechnologies Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Party NameAdaptive Biotechnologies Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Party NameAdaptive Biotechnologies Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, October 29, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, October 28, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, October 17, 2022USE AMENDMENT FILED
Wednesday, October 26, 2022SOU EXTENSION 2 GRANTED
Monday, October 17, 2022SOU EXTENSION 2 FILED
Wednesday, October 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 17, 2022TEAS EXTENSION RECEIVED
Monday, October 17, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, May 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2022SOU EXTENSION 1 GRANTED
Monday, May 2, 2022SOU EXTENSION 1 FILED
Monday, May 2, 2022TEAS EXTENSION RECEIVED
Tuesday, November 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 7, 2021CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 25, 2021ASSIGNED TO PETITION STAFF
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, August 15, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, August 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 28, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, July 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 28, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, July 28, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 20, 2021ASSIGNED TO EXAMINER
Sunday, April 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 14, 2021NEW APPLICATION ENTERED IN TRAM